BRIEF-Theraclion announces FDA authorization to start US trial for immunotherapy and echotherapy combination on …ReutersSAO PAULO, June 26 The Brazilian unit of U.S. food processor Cargill agreed to sell a fruit processing plant located in the Sao Pa… Continue reading
|
Theraclion Announces FDA Authorization to Start US Trial for Immunotherapy and Echotherapy Combination on Breast …
Business Wire (press release) Immunotherapy stimulates the body’s own immune system to fight tumor cells. HIFU, which has already demonstrated its efficacy in the treatment of malignant and benign tumors, could have a major impact on the efficacy of immunotherapy when delivered as … |
Targeted Oncology |
Immunotherapy Combinations Have Mechanistic Rationale in Ovarian Cancer
Targeted Oncology Differential PI3Kδ signaling in CD4+ T cell subsets enables selective targeting of T regulatory cells to enhance cancer immunotherapy. Canc Res. 2017;77(8):1892-1904. doi: 10.1158/0008-5472.CAN-16-1839. Higuchi T, Flies DB, Marion NA, et al. CTLA-4 … |